Dr. Ibert has over 30 years of experience in clinical diagnostics, having held senior positions at international companies, including Hologic, Becton Dickinson, and bioMérieux. She recently served as CEO and now chairs the Board of Gentian Diagnostics ASA, where she played a key role in the company’s growth and success. She is also a board member at Gradientech, a company specializing in ultra-rapid antibiotic susceptibility testing, and VitaDx, a pioneer in AI and image processing in the field of cytology for cancer diagnostics.
Dr. Ibert holds a Ph.D. in Microbiology and a degree in Nutritional Sciences from the Rheinische Friedrich Wilhelms Universität of Bonn, Germany.
